Agbalika, F., Ferchal, F., Garnier, J. P., Eugene, M., Bedrossian, J. & Lagrange, P. H., 1992. False-positive HIV antigens related to emergence of a 25-30kD proteins detected in organ recipients. AIDS 6:959-962. Barbacid, M., Bolognesi, D. & Aaronson, S. A., 1980. Humans have antibodies capable of recognizing oncoviral glycoproteins: Demonstration that these antibodies are formed in response to cellular modification of glycoproteins rather than as consequence of exposure to virus. Proc. Natl. Acad. Sci. U S A 77:1617-1621. Frank, H. 1987. Retroviridae. pp. 253-256, in Animal Virus and Structure, edited by M. V. Nermut and A. C. Steven, Elsevier, Oxford. Gallagher, R. E. & Gallo, R. C., 1975. Type C RNA Tumor Virus Isolated from Cultured Human Acute Myelogenous Leukemia Cells. Science 187:350-353. Gallo, R. C., Sarin, P. S., Kramarsky, B., Salahuddin, Z., Markham, P. & Popovic, M., 1986. First isolation of HTLV-III. Nature 321:119. Gallo, R. C., Wong-Staal, F., Reitz, M., Gallagher, R. E., Miller, N. & Gillepsie, D. H. 1976. Some evidence for infectious type-C virus in humans. pp. 385-405, in Animal Virology, edited by D. Balimore, A. S. Huang and C. F. Fox, Academic Press Inc., New York. Gelderblom, H. R., Bozel, M., Hausmann, E. H. S., Winkel, T., Pauli, G. & Koch, M. A., 1988. Fine Structure of Human Immunodeficiency Virus (HIV), Immunolocalization of Structural Proteins and Virus-Cell Relation. Micron Microscopica 19:41-60. Genesca, J., Jett, B. W., Epstein, J. S. & Bloggs, 1989. What do Western Blot indeterminate patterns for Human Immunodeficiency Virus mean in EIA-negative blood donors? Lancet ii:1023-1025. Grafe, A., 1991. A History of Experimental Virology. Springer-Verlag, Heidelberg. Hodgkinson, N., 1996. AIDS: The Failure of Contemporary Science. Fourth Estate, London. Kashala, O., Marlink, R., Ilunga, M., Diese, M., Gormus, B., Xu, K., Mukeba, P., Kasongo, K. & Essex, M., 1994. Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan. J. Infect. Dis. 169:296-304. Kozhemiakin, L. A. & Bondarenko, I. G., 1992. Genomic instability and AIDS. Biochimiia 57:1417-1426. Layne, S. P., Merges, M. J., Dembo, M., Spouge, J. L., Conley, S. R., Moore, J. P., Raina, J. L., Renz, H., Gelderblom, H. R. & Nara, P. L., 1992. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virol. 189:695-714. Levy, J. A., 1996. Infection by human immunodeficiency virus-CD4 is not enough. NEJM 335:1528-1530. Lundberg, G. D., 1988. Serological Diagnosis of Human Immunodeficiency Virus Infection by Western Blot Testing. JAMA 260:674-679. Maddox, J., 1992. More on Gallo and Popovic. Nature 357:107-109. Mortimer, P., Codd, A., Connolly, J., Craske, J., Desselberger, U., Eglin, R., Follett, E., Hawkins, J., Kurtz, J., Parry, J., Roome, A., Samuel, D., Skidmore, S. & Tedder, R., 1992. Towards error free HIV diagnosis: notes on laboratory practice. Pub. Health Lab. Service Micrbiol. Digest 9:61-64. Muller, W. E. G., Bachmann, M., Weiler, B. E., Schroder, H. C., Uhlenbruck, G. U., Shinoda, T., Shimizu, H. & Ushijima, H., 1991. Antibodies against defined carbohydrate structures of Candida albicans protect H9 cells against infection with human immunodeficiency virus-1 in vitro. J. Acquir. Immun. Defic. Syndr. 4:694-703. Panem, S., 1979. C Type Virus Expression in the Placenta. Current Topics in Pathology 66:175-189. Papadopulos-Eleopulos, E., Turner, V. F., Papdimitriou, J. M., Causer, D., Hedland-Thomas, B. & Page, B., 1994. A critical analysis of the HIV-T4-cell-AIDS hypothesis. Genetica 95:5-24. Sinoussi, F., Mendiola, L. & Chermann, J. C., 1973. Purification and partial differentiation of the particles of murine sarcoma virus (M. MSV) according to their sedimentation rates in sucrose density gradients. Spectra 4:237-243. Snyder, H. W. & Fleissner, E., 1980. Specificity of human antibodies to oncovirus glycoproteins: Recognition of antigen by natural antibodies directed against carbohydrate structures. Proc. Natl. Acad. Sci. U S A 77:1622-1626. Strandstrom, H. V., Higgins, J. R., Mossie, K. & Theilen, G. H., 1990. Studies with canine sera that contain antibodies which recognize human immunodeficiency virus structural proteins. Cancer Res. 50:5628s-5630s. Toplin, I., 1973. Tumor Virus Purification using Zonal Rotors. Spectra No. 4:225-235. WHO, 1994. HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. AIDS Res. Hum. Retroviruses 10:1327-134.
|